About Ataraxis AI
Transforming Cancer Care with AI Precision Medicine
- Industry
- Artificial Intelligence
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Founded
- 2023
- Company type
- Privately Held
Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data.
Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.
Company locations
169 Madison Ave, New York, NY 10016, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 5,346
- People linked to this company
- 41
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.